HEC-96719
- Generic Name
- HEC-96719
A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis
- First Posted Date
- 2022-05-31
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 68
- Registration Number
- NCT05397379
- Locations
- 🇨🇳
Hunan Provincial People's Hospital, Changsha, Hunan, China
🇨🇳NanFang Hospital of Southern Medical University, Guangzhou, Guangdong, China
🇨🇳Union Hospital, TongJi Medical College, HuaZhong University of Science and Technology, Wuhan, Hubei, China
Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects
- First Posted Date
- 2020-09-14
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT04546984
- Locations
- 🇨🇳
The Shanghai xuhui district central hospital, Shanghai, Shanghai, China
The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects
Phase 1
Completed
- Conditions
- Non-alcoholic Fatty Liver DiseaseNon-alcoholic Steatohepatitis
- Interventions
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2021-05-07
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 73
- Registration Number
- NCT04422496
- Locations
- 🇦🇺
Nucleus Network Pty Ltd, Melbourne, Melbourne VIC 3004, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath